|SARS-CoV-2 501Y. V2 escapes neutralization by South African COVID-19 donor plasma|
CK Wibmer, F Ayres, T Hermanus, M Madzivhandila, P Kgagudi, ...
Nature medicine 27 (4), 622-625, 2021
|International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009|
WK Roth, MP Busch, A Schuller, S Ismay, A Cheng, CR Seed, ...
Vox Sanguinis 102 (1), 82-90, 2012
|Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7|
NF Parrish, CB Wilen, LB Banks, SS Iyer, JM Pfaff, JF Salazar-Gonzalez, ...
PLoS pathogens 8 (5), e1002686, 2012
|Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges|
EM Bloch, M Vermeulen, E Murphy
Transfusion medicine reviews 26 (2), 164-180, 2012
|Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South …|
M Vermeulen, N Lelie, W Sykes, R Crookes, J Swanevelder, L Gaggia, ...
Transfusion 49 (6), 1115-1125, 2009
|Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms|
J Weusten, M Vermeulen, H van Drimmelen, N Lelie
Transfusion 51 (1), 203-215, 2011
|Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 …|
LH Ping, SB Joseph, JA Anderson, MR Abrahams, JF Salazar-Gonzalez, ...
Journal of virology 87 (13), 7218-7233, 2013
|Characterization of occult hepatitis B virus strains in South African blood donors|
JP Allain, D Belkhiri, M Vermeulen, R Crookes, R Cable, A Amiri, R Reddy, ...
Hepatology 49 (6), 1868-1876, 2009
|Hepatitis B virus transmission by blood transfusion during 4 years of individual‐donation nucleic acid testing in South Africa: estimated and observed window period risk|
M Vermeulen, C Dickens, N Lelie, E Walker, C Coleman, M Keyter, ...
Transfusion 52 (4), 880-892, 2012
|Features of recently transmitted HIV-1 clade C viruses that impact antibody recognition: implications for active and passive immunization|
C Rademeyer, B Korber, MS Seaman, EE Giorgi, R Thebus, A Robles, ...
PLoS pathogens 12 (7), e1005742, 2016
|Epidemiology of human parvovirus 4 infection in sub-Saharan Africa|
CP Sharp, M Vermeulen, Y Nébié, CF Djoko, M LeBreton, U Tamoufe, ...
Emerging infectious diseases 16 (10), 1605, 2010
|The use of rapid diagnostic tests for transfusion infectious screening in Africa: a literature review|
CR Pruett, M Vermeulen, P Zacharias, C Ingram, CT Tagny, EM Bloch
Transfusion Medicine Reviews 29 (1), 35-44, 2015
|Sensitivity of individual‐donation and minipool nucleic acid amplification test options in detecting window period and occult hepatitis B virus infections|
M Vermeulen, C Coleman, J Mitchel, R Reddy, H van Drimmelen, T Ficket, ...
Transfusion 53 (10pt2), 2459-2466, 2013
|Detection of different categories of hepatitis B virus (HBV) infection in a multi‐regional study comparing the clinical sensitivity of hepatitis B surface antigen and HBV‐DNA …|
N Lelie, R Bruhn, M Busch, M Vermeulen, WC Tsoi, S Kleinman, ...
Transfusion 57 (1), 24-35, 2017
|Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐and low‐middle‐income countries|
EM Bloch, R Goel, S Wendel, T Burnouf, AZ Al‐Riyami, AL Ang, ...
Vox sanguinis 116 (1), 18-35, 2021
|Pilot studies for development of an HIV subtype panel for surveillance of global diversity|
M Manak, S Sina, B Anekella, I Hewlett, E Sanders-Buell, V Ragupathy, ...
AIDS research and human retroviruses 28 (6), 594-606, 2012
|Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology …|
M Vermeulen, N Lelie, C Coleman, W Sykes, G Jacobs, R Swanevelder, ...
Transfusion 59 (1), 267-276, 2019
|A mathematical model for estimating residual transmission risk of occult hepatitis B virus infection with different blood safety scenarios|
J Weusten, H van Drimmelen, M Vermeulen, N Lelie
Transfusion 57 (3pt2), 841-849, 2017
|Comparison of human immunodeficiency virus assays in window phase and elite controller samples: viral load distribution and implications for transmission risk|
M Vermeulen, C Coleman, J Mitchel, R Reddy, H van Drimmelen, ...
Transfusion 53 (10pt2), 2384-2398, 2013
|A mathematical approach to estimate the efficacy of individual‐donation and minipool nucleic acid amplification test options in preventing transmission risk by window period …|
M Vermeulen, H van Drimmelen, C Coleman, J Mitchel, R Reddy, N Lelie
Transfusion 54 (10), 2496-2504, 2014